Neogenomics (NEO) Gross Margin (2010 - 2026)
Neogenomics' (NEO) quarterly Gross Margin came in at 45.56% in Q2 2026, up 296.0% YoY from 11.51% in Q2 2025, and up 5.18% on a QoQ basis from 43.32% in Q1 2026.
Neogenomics (NEO) Gross Margin (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has 17 years of Gross Margin data on file, last reported at 45.56% in Q2 2026.
- Quarterly Gross Margin rose 296.0% year-over-year to 45.56% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 43.92% (changed 0.0% YoY) and the FY2025 annual result came in at 43.21%, down 71.0% from the prior year.
- Gross Margin climbed to 45.56% in Q2 2026, from 43.32% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 45.56% in Q2 2026 to a low of 32.63% in Q1 2022.
- A 5-year average of 41.62% and a median of 42.72% in 2025 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin sank 840 bps — and 2023, when it soared 732 bps.
- Tracing NEO's Gross Margin over 5 years: stood at 40.97% in 2022, then grew by 6 bps to 43.45% in 2023, then advanced by 3 bps to 44.92% in 2024, then dropped by 2 bps to 43.83% in 2025, then advanced by 4 bps to 45.56% in 2026.
- The last three Gross Margin figures came in at 45.56% (Q2 2026), 43.32% (Q1 2026), and 43.83% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 69.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 57.64% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 64.04% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 53.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 32.85% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 99.91% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 66.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 63.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 33.75% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | 45.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.56% |
| Mar 31, 2026 | 43.32% |
| Dec 31, 2025 | 43.83% |
| Sep 30, 2025 | 42.84% |
| Jun 30, 2025 | 42.61% |
| Mar 31, 2025 | 43.59% |
| Dec 31, 2024 | 44.92% |
| Sep 30, 2024 | 44.62% |
| Jun 30, 2024 | 44.07% |
| Mar 31, 2024 | 41.90% |
| Dec 31, 2023 | 43.45% |
| Sep 30, 2023 | 41.01% |
| Jun 30, 2023 | 40.77% |
| Mar 31, 2023 | 39.95% |
| Dec 31, 2022 | 40.97% |
| Sep 30, 2022 | 37.97% |
| Jun 30, 2022 | 35.14% |
| Mar 31, 2022 | 32.63% |
| Dec 31, 2021 | 35.99% |
| Sep 30, 2021 | 38.93% |